Program: Oral and Poster Abstracts
Session: 322. Disorders of Coagulation or Fibrinolysis: Poster II
Methods: Plasma samples from 75 patients with confirmed DIC were included in this study. 50 plasma samples from normal healthy individuals were obtained from a commercial source (George King Biomedical, Overland Park, KS). Endocan, VEGF, sCD40L, and IL-6 were measured using commercially available sandwich ELISA assays (Lunginnov, Lillie, France/R&D Systems, Minneapolis, MN). Microparticles, and microparticles expressing tissue factor were measured using commercially available functional assays (Hyphen Biomedical, Paris, France).
Results: All inflammatory biomarkers were significantly elevated in DIC MP-TF (DIC- 1.85±1.3 pg/ml; N-0.39.6±0.2 pg/ml, p<0.001) , sCD40L (DIC-618±571 pg/ml; N-177.6±221.4 pg/ml, p<0.00) VEGF (DIC->740 pg/ml; N-32.6±50.9 pg/ml, p=0.007), endocan (DIC-10.6 ng/ml±10.9; N-1.81±0.36 ng/ml, p<0.001) and IL-6 (DIC-4968±5719 pg/ml; N-59.2±118.1 pg/ml, p<0.001). Microparticles were elevated compared to normal (p<0.001) and correlated significantly with sCD40L (p=0.0005) and VEGF (0.039). sCD40L and VEGF also correlated significantly (p=0.001)
Discussion: The correlation between microparticles, sCD40L and VEGF found in these patients strongly supports the widespread activation of platelets in DIC. It is possible that this process contributes to the thrombocytopenia often seen in sepsis. In addition there was an elevation in both endocan and VEGF suggesting that, while endocan may have an effect on the level of VEGF in vivo, platelets appear to be the major source. Interestingly, microparticles specifically carrying tissue factor did not show correlation with any of the other biomarkers. This may be because these microparticles may be shed from multiple sources, particularly both activated monocytes and endothelial cells, and this may have been a confounding factor. Thus, these results provide further evidence of the widespread inflammatory milieu present in patients with DIC, particularly elucidating possible cross-talk between platelets and endothelium. Profiling of these biomarkers may be helpful in the risk stratification of patients with sepsis associated coagulopathy and following their clinical progress.
Disclosures: No relevant conflicts of interest to declare.
See more of: Disorders of Coagulation or Fibrinolysis
See more of: Oral and Poster Abstracts
*signifies non-member of ASH